chr11-102955390-A-G

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate

The NM_002427.4(MMP13):​c.224T>C​(p.Phe75Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 32)

Consequence

MMP13
NM_002427.4 missense

Scores

11
4
4

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 9.19
Variant links:
Genes affected
MMP13 (HGNC:7159): (matrix metallopeptidase 13) This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease cleaves type II collagen more efficiently than types I and III. It may be involved in articular cartilage turnover and cartilage pathophysiology associated with osteoarthritis. Mutations in this gene are associated with metaphyseal anadysplasia. This gene is part of a cluster of MMP genes on chromosome 11. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.955
PP5
Variant 11-102955390-A-G is Pathogenic according to our data. Variant chr11-102955390-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 9443.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-102955390-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMP13NM_002427.4 linkc.224T>C p.Phe75Ser missense_variant Exon 2 of 10 ENST00000260302.8 NP_002418.1 P45452Q53H33

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMP13ENST00000260302.8 linkc.224T>C p.Phe75Ser missense_variant Exon 2 of 10 1 NM_002427.4 ENSP00000260302.3 P45452
MMP13ENST00000340273.4 linkc.224T>C p.Phe75Ser missense_variant Exon 2 of 11 1 ENSP00000339672.4 G5E971

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Oct 27, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 75 of the MMP13 protein (p.Phe75Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant spondyloepimetaphyseal dysplasia, Missouri type (PMID: 16167086). It has also been observed to segregate with disease in related individuals. This variant is also known as F56S. ClinVar contains an entry for this variant (Variation ID: 9443). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MMP13 protein function. Experimental studies have shown that this missense change affects MMP13 function (PMID: 16167086). For these reasons, this variant has been classified as Pathogenic. -

Spondyloepimetaphyseal dysplasia, Missouri type Pathogenic:1
Oct 01, 2005
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Pathogenic
0.29
D
BayesDel_noAF
Pathogenic
0.17
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.32
T;T;.
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Benign
0.82
T;T;T
M_CAP
Uncertain
0.085
D
MetaRNN
Pathogenic
0.95
D;D;D
MetaSVM
Benign
-0.54
T
MutationAssessor
Pathogenic
3.1
M;.;.
PrimateAI
Uncertain
0.61
T
PROVEAN
Pathogenic
-6.6
D;.;D
REVEL
Pathogenic
0.77
Sift
Uncertain
0.0010
D;.;D
Sift4G
Pathogenic
0.0010
D;D;D
Polyphen
1.0
D;.;.
Vest4
0.92
MutPred
0.83
Gain of disorder (P = 0.0021);Gain of disorder (P = 0.0021);Gain of disorder (P = 0.0021);
MVP
0.86
MPC
0.58
ClinPred
1.0
D
GERP RS
5.8
Varity_R
0.89
gMVP
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121909497; hg19: chr11-102826119; API